RSS Items

US group races to overcome production bottleneck to meet demand for anti-obesity medicine Zepbound

Shares of world’s most valuable pharmaceuticals group reapproach record highs

Drugmaker forecasts higher than expected annual revenue due to soaring demand for weight-loss medication

US group hunts for outsourcers to lift production of Zepbound as it takes on Danish group’s Wegovy blockbuster

Shares soar as ‘strong performance’ of Mounjaro and Zepbound medicines underpin jump in revenue

Point is developing radioligand molecules that can deliver targeted radiation to tumour cells

Cheaper valuations have finally drawn back cash-rich pharmaceutical makers

Mounjaro has achieved 22.5 per cent loss of body weight in trials